A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptoms
Expert Rev Clin Pharmacol. 2025 Apr 20. doi: 10.1080/17512433.2025.2495951. Online ahead of print. ABSTRACT INTRODUCTION: Fezolinetant is a first-in-class non-hormonal pharmacological treatment recently approved for …